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IMPACT OF INITIAL 
FLUSH POTASSIUM 
CONCENTRATION ON THE 
ADEQUACY OF LUNG 
PRESERVATION 
The effects of initial lung flushing with intracellular and extracellular fluid type 
solutions were studied in lungs stored with the University of Wisconsin solution. 
Excised Sprague-Dawley rat lungs (n = 39) were flushed first with one of the 
following solutions: (1) the University of Wisconsin solution (K + = 140 mmol /L) ,  (2) 
modified (low potassium) University of Wisconsin solution (K + = 20 mmol/L), 
(3) phosphate buffered saline solution (K + = 3.9 mmol/L), (4) modified 
low-potassium phosphate-buffered saline solution (K + = 20 mmol/L), (5) 
modified high-potassium phosphate-buffered saline solution (K + = 40 mmol/L), 
and (6) Euro-Collins solution (K + = 115 mmol/L) followed by secondary flush with 
storage solution and cold (4 ° C) storage in University of Wisconsin solution for 24 
hours. The lungs were then reperfused in the isolated, pulsatile, blood-perfused 
working lung system for 2 hours or until lung failure. Blood gas analysis and shunt 
fraction, aerodynamic parameters (airway resistance, lung compliance, lastic work, 
and flow resistive work), and total pulmonary vascular esistance were measured 
throughout he perfusion period. The mean oxygen tensions (in millimeters of 
mercury) at 30 minutes after the onset of reperfusion for University of Wisconsin 
solution, modified University of Wisconsin solution, phosphate-buffered saline 
solution, modified phosphate-buffered saline solutions (20 and 40 mmol/L), and 
Euro-Collins solution were 56.1 - 4.2, 72.7 -+ 9.1, 87.7 _ 6.9 (p < 0.01 versus 
University of Wisconsin solution;p < 0.01 versus Euro-Collins solution), 86.0 -+ 9.6 
(p < 0.01 versus University of Wisconsin solution; p < 0.01 versus Euro-Collins 
solution), 87.9 - 7.7 (p < 0.01 versus University of Wisconsin solution; p < 0.01 
versus Euro-Collins solution), and 53.5 - 6.0, respectively. All aerodynamic 
parameters in the lungs flushed with extracellular fluid type solutions were superior 
to those flushed with intracellular fluid type solutions. We conclude that the efficacy 
of initial flushing was essential for successful lung preservation and that extracel- 
lular fluid type solutions were superior to intracellular fluid type solutions, at least 
for flushing the lung before storage with University of Wisconsin solution. Potas- 
sium concentration i  flushing solution should be 20 mmol/L or less to obtain 
appropriate flushing and subsequent adequate distribution of the storage solution. 
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I n the current standard procedures for lung trans- 
plantation, Euro-Collins solution (ECS) and the 
University of Wisconsin solution (UWS) are widely 
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used for the flushing and storage of the lung graft. 1' 2 
The two solutions have similar electrolyte composi- 
tions of the intracellular fluid type, with low sodium 
and high potassium concentrations. However, solu- 
tions with high potassium concentration have been 
reported to cause severe vasoconstriction. 3'4 They 
would be unsuitable for flushing the lung graft because 
vasoconstriction would produce poor distribution of 
the perfusate. The recent development of extracellular 
fluid type solutions for lung preservation, 5-1° such as 
low-potassium dextran solution or low-potassium 
UWS, provides the possibility of extended lung pres- 
ervation, but intracellular fluid type solution is still 
believed to be beneficial for organ storage, a' 2 
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Table I. Composition of colloidal flushing solutions 
UWS mUWS 
Hydroxyethyl starch (gin/L) 50 50 
Lactobionic acid (mmol/L) 100 100 
RalIinose (mmol/L) 30 30 
Adenosine (mmol/L) 5 5 
Allopurinol (mmol/L) 1 1 
Glutathione (mmol/L) 3 3 
KH2PO 4 (mmol/L) 25 20 
NaH2PO 4(mmol/L) 5 
MgSO4 (retool/L) 5 5 
KOH (mmol/L) 115 
NaOH (mmol/L) 20 135 
Total Na + (mmol/L) 20 140 
Total K + (mmol/L) 140 20 
pH 7.4 7.4 
Osmolarity (mOsm) 320 320 
Previous studies in which extracellular fluid type 
solutions were compared with intracellular type 
solutions for lung preservation used the same solu- 
tion for both flushing and storage. 5-8' 10 Yamazaki 
and associates, 9 studying flushing and storage solu- 
tions, demonstrated high vascular esistance in lungs 
initially flushed with high-potassium solutions. They 
postulated that this was a direct effect of high 
potassium concentration but did not determine the 
pharmacologic threshold of this effect. We postu- 
lated that the two procedures of flushing and storage 
should be investigated separately, inasmuch as they 
might have different purposes. An important role of 
initial flushing in lung preservation is the removal of 
blood from the pulmonary vascular bed, which 
otherwise would impair lung function after storage 
by plugging the vessels, preventing the tissue from 
cooling, and allowing for membranous damage by 
macrophages and neutrophils that would remain 
during preservation. 11'12 We presumed that the 
superiority of extracellular over intracellular fluid 
type solutions recently demonstrated was mostly due 
to better flushing, and we focused on the flushing 
procedure in this study. The purpose of this study 
was to investigate separately the effect of flushing 
with different types of Solutions, followed by stan- 
dard procedures for lung storage, and to determine 
the ultimate composition of the flushing solution for 
lung preservation. 
Materials and methods 
Male Sprague-Dawley rats weighing 325 to 350 gm were 
obtained from Taconic Farms (Germantown, N.Y.) and 
were allowed free access to food and water. Housing and 
Table II. Composition of crystalloid flushing 
solutions 
DPBS mPBS1 mPBS2 EC 
NaC1 (retool/L) 138 124 104 
KC1 (retool/L) 2.7 18.8 38.8 15 
Na2HPO4 (mmol/L) 8.1 8.1 8.1 
KH2PO 4 (mmol/L) 1.2 1.2 1.2 15 
K2HPO4 (mmol/L) 42.5 
NaHCO 3 (mmol/L) 10 
Glucose (mmol/L) 139 
Total K + (mmol/L) 3.9 20 40 115 
Total Na ÷ (mmol/L) 154 140 120 10 
pH 7.4 7.4 7.4 7.4 
Osmolarity (mOsm) 282 286 286 306 
experiments conformed to the U.S. National Institutes of 
Health, New England Deaconess Hospital, and Harvard 
Medical School regulations for animal care and use of 
laboratory animals. Unless otherwise stated, all reagents 
were purchased from Sigma Chemical Company (St. 
Louis, Mo). 
Experimental procedures and protocol. The procedure 
for harvesting rat lungs was previously described. 13After 
cannulation of the pulmonary artery, the lungs were 
initially flushed in situ with cold (4 ° C) flushing solution, 
100 ml/kg body weight, from a height of 30 cm. Excised 
lungs (n = 39) were divided into the following six groups 
according to the type of initial flushing solution: group 1 
(n = 6), the UWS (K + = 140 retool/L); group 2 (n = 6): 
modified (low-potassium) UWS (mUWS; K + = 20 mmol/ 
L); group 3 (n = 7), Dulbecco's phosphate-buffered saline 
solution (DPBS; K + = 3.9 mmol/L); group 4 (n = 7), 
modified (low potassium) PBS (mPBS1; K + = 20 retool/ 
L); group 5 (n = 7), modified (high potassium) PBS 
(mPBS2; K + = 40 retool/L); group 6 (n = 6), ECS (K + = 
115 retool/L). These solutions were selected from the 
representative crystalloid or colloidal solutions with dif- 
ferent potassium concentrations. The composition of each 
solution is shown in Tables I and II. The initial flushing 
was followed by a secondary flushing with cold storage 
solution (UWS, 50 ml/kg) to prevent he initial flushing 
solution from remaining in the lung during the storage 
period. The lungs and heart were then harvested en bloc 
and stored, half-inflated with room air, for 24 hours at 
4 ° C. All lungs were stored in UWS. The experimental 
protocol for flushing and storage is summarized in Table 
III. 
After storage for 24 hours in the UWS, all lungs were 
reperfused with fresh homologous venous blood exsangui- 
nated from donor rats to allow for the evaluation of lung 
function by means of the previously described isolated, 
pulsatile, blood-perfused working lung model. 13 Total 
pulmonary vascular esistance (in millimeters of mercury 
per millimeter per minute) was calculated and assessed. 
Vascular resistance was calculated both during flushing 
and during the perfusion period. Lung airway resistance 
(centimeters of water per milliliter per second) and dy- 
namic lung compliance (milliliters per centimeter of wa- 
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Fig. 1. Changes in oxygen tension (Po2) during the reper- 
fusion period. **p < 0.01 versus UWS; ##p < 0.01 versus 
ECS. 
ter) were calculated from the airway volume-pressure 
loop. 14 Shunt fraction (percent) was calculated by the 
results of blood gas analysis: 5 The lungs were perfused 
for 2 hours or until lung failure occurred. The perfusion 
time (up to 2 hours) was recorded as lung survival time. 
Statistical analysis. All results were expressed as 
means _+ standard error of the mean, and differences were 
considered significant at the p < 0.05 level. Data from all 
groups were compared by one-way analysis of variance 
with post hoc pairwise comparisons (Tukey-Kramer). 
Results 
Vascular resistance during flushing. Vascular re- 
sistance during flushing was used to reflect he degree 
of vasoconstriction during flushing. Vascular resis- 
tance (millimeters of mercury per milliliter per 
minute) for the various flushing solutions was as 
follows: UWS, 0.86 ± 0.07; mUWS, 0.43 _ 0.02 (p < 
0.01 versus UWS); DPBS, 0.18 _+ 0.02 (p < 0.01 versus 
UWS;p < 0.01 versus ECS); mPBS1, 0.21 _+ 0.04 (p < 
0.01 versus UWS; p < 0.01 versus ECS); mPBS2, 0.25 
_+ 0.02 (p < 0.01 versus UWS; p < 0.01 versus ECS); 
ECS, 0.50 _+ 0.02 (p < 0.01 versus UWS). Significantly 
higher vascular resistances were found with intracellu- 
1at fluid type solutions, which indicates that high- 
potassium solutions were associated with vasoconstric- 
Table III. Experimentalprotocol 
Group Initial flushing solution 
Second 
flushing and 
storage 
solution 
Group 1 UW (colloid, K + = UW, storage 
(n = 6) 140 mmol/L) for 24 hr 
Group 2 mUW (colloid, K + = UW, storage 
(n = 6) 20 mmol/L) for 24 hr 
Group 3 DPBS (crystalloid, K + = UW, storage 
(n = 7) 3.9 retool/L) for 24 hr 
Group 4 mPBS1 (crystalloid, K + = UW, storage 
(n = 7) 20 retool/L) for 24 hr 
Group 5 mPBS2 (crystalloid, K + = UW, storage 
(n = 7) 40 mmol/L) for 24 hr 
Group 6 EC (crystalloid, K + = UW, storage 
(n = 6) 115 mmol/L) for 24 hr 
tion during flushing. Vascular resistance measured 
during reperfusion was not different between groups. 
Lung survival time. Lung survival time is indi- 
cated as the time until lung failure or 2 hours of 
reperfusion. Mean lung survival time (minutes) for 
each group was as follows: UWS, 30.0 + 1.3, 
mUWS, 110.0 _+ 10.0 (p < 0.01 versus UW;p < 0.01 
versus EC); DPBS, 120.0 + 0.0 (p < 0.01 versus 
UW;p < 0.01 versus EC); mPBS1, 117.9 _+ 2.1 (p < 
0.01 versus UW; p < 0.01 versus EC); mPBS2, 92.1 
_+ 13.3 (p < 0.01 versus UW; p < 0.01 versus EC); 
ECS, 34.2 _+ 11.7. These data indicated that the 
lungs remained viable and maintained the ability for 
oxygenation for a longer period in the group flushed 
with low-potassium solution than with high-potas- 
sium solution. Lung survival times in mPBS2 (K + = 
40 retool/L) were significantly lower than those in 
groups flushed with solutions containing a 20 
mmol/L concentration of potassium or less (DPBS; 
K + = 3.9 retool/L) (p < 0.05). 
Blood gas analysis and shunt fraction. The par- 
tial pressure of oxygen is currently regarded as the 
most important parameter in allowing for the assess- 
ment of lung graft function, a6 Fig. 1 shows the 
oxygen tension during reperfusion after storage. 
Mean values for the DPBS, mPBS1, and mPBS2 
groups were significantly higher than for either the 
ECS or UWS groups (p < 0.01). Values for mean 
oxygen tensions were maintained within physiologic 
ranges during the perfusion period. The values for 
shunt fraction indicated a similar trend to those of 
oxygen tension. Shunt fractions at 30 minutes after 
the onset of reperfusion for UWS, mUWS, DPBS, 
mPBS1, mPBS2, and ECS groups were 40.6% _+ 
8.3%, 16.4% _+ 4.9% (p < 0.05 versus UWS; p < 
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Fig. 2. Changes of the dynamic ompliance (DC) during the reperfusion period. *p < 0.05; **p < 0.01 
versus UWS, #p < 0.05; ##p < 0.01 versus ECS. 
0.05 versus ECS), 12.8% _+ 2.4% (p < 0.05 versus 
UWS; p < 0.05 versus ECS), 12.0% _+ 2.2% (p < 
0.05 versus UWS; p < 0.05 versus ECS), 20.7% _+ 
7.2%, and 36.8% _+ 8.7%, respectively. Values re- 
mained stable for 2 hours except in the UWS and 
ECS groups, in which values deteriorated within 30 
minutes of perfusion. 
Lung airway resistance and dynamic lung com- 
pliance. Values for the lung airway resistance (cen- 
timeters of water per milliliter per second) at the 
onset of reperfusion for UWS, mUWS, DPBS, 
mPBS1, mPBS2, and ECS groups were 4.25 _+ 0.43, 
2.85 _+ 0.12 (p < 0.01 versus UWS;p < 0.05), 3.11 _+ 
0.12 (p < 0.01 versus UWS), 3.08 _+ 0.21 (p < 0.01 
versus UWS), 3.23 _+ 0.13 (p < 0.05), and 3.62 _+ 
0.14, and those values at 30 minutes of perfusion 
were 5.76 _+ 0.93, 2.82 _+ 0.16 (p < 0.01 versus UWS; 
p < 0.05), 3.06 _+ 0.17 (p < 0.01 versus UWS; p < 
0.05), 2.78 _+ 0.16 (p < 0.01 versus UWS; p < 0.01 
versus ECS), 3.68 + 0.32 (p < 0.05), and 4.95 +_ 
0.52, respectively. Values for the mUWS, DPBS, 
and mPBS1 groups were significantly better than 
those for either the UWS or ECS groups and 
remained stable during 2 hours of the perfusion 
period. Fig. 2 shows changes of the dynamic lung 
compliance (milliliters per centimeter of water). 
Dynamic lung compliance remained stable for 2 
hours in the groups flushed with low-potassium 
perfusate but deteriorated within 30 minutes in the 
UWS and ECS groups. 
Discussion 
The ultimate composition of lung preservation 
solutions remains controversial. The current stan- 
dard solution for lung preservation is still ECS, 1 
which has the electrolyte composition of an intra- 
cellular type solution, containing high potassium 
and low sodium concentrations. The UWS, which 
has recently demonstrated better results on lung 
preservation, 17-19 is also an intracellular fluid type 
solution. In standard procedures of lung preserva- 
tion, prostaglandin E 1 (500 txg) is usually given by 
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direct injection into the pulmonary artery before 
flushing to produce pulmonary vasodilation and to 
enhance distribution of the flush solution, because 
solutions with high potassium concentrations have 
been shown to cause vasoconstriction. 1' 3,4 
Keshavjee and associates 5'7 recently demon- 
strated the superiority of low-potassium dextran 
solution and low-potassium UWS, extracellular fluid 
type solutions, on lung preservation. They have also 
demonstrated that prostaglandin E a does not en- 
hance the effect of low-potassium dextran solution 
on lung preservation. 2° These studies evaluated lung 
function after preservation with the use of the same 
solution for both flushing and storage and did not 
investigate separately the effect of each solution for 
flushing and for storage. Therefore, the question 
remains as to the benefits of the extracellular fluid 
type solution versus intracellular fluid type solution 
both for flushing and for storage. In this study, we 
used UWS for storage for two reasons. First, UWS 
is a standard solution in current clinical use for lung 
preservation. Second, we wished to eliminate the 
species difference of xanthine oxidase activity be- 
tween human beings and rats. UWS contains allo- 
purinol, which inhibits the high activity of xanthine 
oxidase in rat species. 
Our results demonstrate that flushing with an 
extracellular fluid type solution is superior to flush- 
ing with an intracellular fluid type solution regard- 
less of colloid or crystalloid type when lung function 
is compared after 24 hours of storage in UWS. 
Moreover, our data demonstrate hat initial flushing 
is essential for successful lung preservation. In ad- 
dition, we have shown that the potassium concen- 
tration in the flushing solution should be 20 mmol/L 
or less. This potassium concentration is consistent 
with the threshold values that have been shown to 
induce vasoconstriction i the rat pulmonary ar- 
tery. 3 
It must be acknowledged that rodent lungs are 
very sensitive to potassium concentration changes as 
demonstrated by this current study, as well as by 
those performed on rabbits by Yamazaki and asso- 
ciates. 9 Pulmonary resistance in rodents and other 
animals can be modified by methods other than 
manipulating the potassium concentration, such as 
pretreatment with prostaglandin E a or lung hyper- 
inflation, m It is possible but not proven that the less 
sensitive human lungs may be adequately perfused if
these methods are used. In fact, preliminary inves- 
tigations in our laboratory suggest that the effect of 
prostaglandin E~ is transient, with its action as short 
as 20 to 30 seconds, which may or may not be 
sufficient ime for instillation of the preservation 
solution. Certainly, low initial potassium concentra- 
tions, even in rodents, will eliminate the concern 
about adequate solution delivery. 
The present study demonstrates that extracellular 
fluid type solutions are superior to intracellular fluid 
type solutions, at least for flushing. The question of 
which solution is best for lung storage remains 
unresolved. In general, intracellular fluid type solu- 
tions have been considered more beneficial for 
organ storage than extracellular fluid type solu- 
tions, 21 because the electrolyte composition (high 
potassium and low sodium) would not involve the 
Na +, K + exchange pump and therefore not require 
the cellular membrane to consume adenosine 
triphosphate. 
In addition, this composition would prevent Na ÷ 
influx into the cell and prevent cell swelling. Intra- 
cellular fluid type solutions may, however, have the 
disadvantage of calcium regulation. Calculated 
membrane potential is nearly 0 mV under condi- 
tions in which the potassium concentration of intra- 
cellular and extracellular fluid is almost the same 
(Nernst equation). Cellular membranes are com- 
pletely depolarized under these conditions, which 
would result in calcium accumulation through the 
opening of the voltage-dependent calcium channels 
during storage with intracellular fluid type solu- 
tions.la, 22-25 Most preservation solutions, such as 
ECS, UWS, and low-potassium dextran solution, are 
calcium-free solutions. We speculate that extracel- 
lular calcium would remain in the lung tissue be- 
cause it could not be depleted by initial flushing. 
Calcium could also be released from sarcoplasmic 
reticulum, which is tightly linked with the plasma 
membrane invascular smooth muscle cells. Another 
disadvantage is that the intracellular fluid type so- 
lution would enhance calcium overload at the time 
of reperfusion by opening the voltage-dependent 
calcium channels because of depolarization and 
would enhance reperfusion injury. TM 25 
In conclusion, we have demonstrated that an 
extracellular fluid type solution was better than an 
intracellular fluid type solution, at least for flushing 
the lung followed by storage with the UWS. Lung 
flushing using extracellular fluid type solution pro- 
vided excellent lung function after storage for 24 
hours. Although prostaglandin E 1 or hyperinflation 
may improve flow, keeping the potassium concen- 
tration in the flushing solution at 20 mmol/L or less 
assures appropriate flushing and adequate distribu- 
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tion of storage solution. It is still uncertain whether 
an extracellular fluid type solution is more beneficial 
than an intracellular fluid type solution for storage; 
however, we recommend that future studies should 
uniformly use a low-potassium extracellular fluid 
type solution for lung flushing as the standard 
method when the effects of storage solutions are 
being compared. 
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Discuss ion 
Dr. Robert A. Guyton (Atlanta, Ga.). When you change: 
the potassium solution you are taking out 80 mEq of 
potassium. What cation are you replacing this with, or 
does the osmolarity of the solution remain the same? 
What is the composition of the low-potassium UWS? Do 
you add sodium to make up for the absence of potassium? 
Dr. Sasaki. PBS and mPBS have the same osmolarity of 
about 290 mOsm. UWS and the modified UWS, both of 
which are colloidal solutions, have the same osmolarity of 
320 mOsm. Potassium was replaced with sodium to main- 
tain the same osmolarity. 
Mr. Nicholas Odom (Manchester, England). We have 
done some similar experiments and we found totally 
different results. We found that the high potassium con-. 
centration worked well and the high sodium concentration 
did not work at all. 
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However, when we changed the conditions of perfusion 
during the first few minutes and reduced the flow and the 
pressure, we got entirely different results. We were unable 
to demonstrate any significant difference. 
Can you be a little more precise about he conditions of 
flow and pressure with which you were perfusing these 
lungs, particularly during the first 10 to 15 minutes of 
reperfusion? During that time you get marked changes in 
pulmonary vascular esistance, particularly in the lungs 
stored in high-potassium solutions. 
Dr. Sasaki. Perfusion commenced at a flow of 0.03 
ml/gm body weight per minute and was gradually in- 
creased to a final flow of 0.1 ml/gm body weight per 
minute with increments of 0.02 ml/gm body weight per 
minute every 5 minutes. The increase in pulmonary vas- 
cular resistance at the onset of reperfusion may result 
from the high-potassium storage solution, as you men- 
tioned. In addition, calcium may enter not only from the 
voltage-dependent calcium channels but also from the site 
of damaged membrane after storage. 
Dr. Shaf Keshavjee (Toronto, Ontario, Canada). Your 
first slide indicated that there was no evidence for im- 
proved storage with the low-potassium dextran solution. 
We have been studying that for several years in Toronto. 
We initially showed that it had improved preservation 
over ECS. We went on to study the role of potassium in 
that solution by varying the concentrations of potassium in 
low-potassium dextran solution without changing anything 
else. We confirmed that the high potassium concentration 
was indeed causing the problem and that a low potassium 
concentration was better. 
In work done by Fumio Yamasaki, who was a fellow in 
our laboratory at the same time, we studied the issue of 
the storage versus the flush phase of preservation. We 
showed that storage in the high-potassium solution was 
deleterious even if storage was preceded by a flush with a 
low-potassium solution initially, whereas torage in low- 
potassium dextran solution produced superior esults. 
Furthermore, we studied the same issue using isolated 
type II pneumocytes in culture and showed that cells 
stored in the low-potassium dextran solution at 5 ° C had 
improved viability. 
Do you have any evidence at all to recommend UWS as 
a storage solution for lung preservation even after a 
low-potassium flush? 
Dr. Sasaki. We used UWS in this study because it is one 
of the standard solutions for lung preservation and be- 
cause it contains allopurinol, which may reduce a high 
activity of the xanthine oxidase in rats. We compared and 
discussed only the effect of flushing solution on lung 
function after storage. Comparisons between the efficacy 
of high-potassium solution and low-potassium solution for 
storage require another study. 
Dr. Frederick L. Grover (Denver, Colo.) Clinically we 
give prostaglandin E 1 before flushing the lungs. Have you 
looked to see whether pre-administration f prostaglandin 
E 1 would affect these results? 
Dr. Sasaki. We did not use prostaglandin E1 in this 
study, because we would like to determine the precise 
effects of potassium concentration i flushing solutions 
influencing lung function after storage. We have examined 
vasodilatory effects of prostaglandin E 1 on high-potassium 
solutions in another study. We have observed that voltage- 
dependent calcium channel blockers were more beneficial 
than prostaglandin E 1 for attenuating vasoconstriction by
high-potassium solutions. 
